X-linked recessive nephrolithiasis is associated with kidney stones and renal tubular dysfunction in childhood progressing to renal failure in adulthood. The primary defect causing this renal tubular disorder is unknown and determining the chromosomal location of the mutant gene would represent an important step toward defining the biochemical basis. We have performed linkage studies in 102 members (10 affected males, 47 unaffected males, 15 obligate heterozygote females, and 30 unaffected females) from five generations of one family. As genetic markers we used 10 cloned human X chromosome fragments identifying restriction fragment length polymorphisms and seven pairs of oligonucleotide primers identifying microsatellite polymorphisms. Linkage with the locus DXS255 was established with a peak LOD score = 5.91 at 3.6% recombination, thereby localizing the X-linked recessive nephrolithiasis gene to the pericentromeric region of the short arm of the X chromosome (Xpl 1.22). Multilocus analysis indicated that the mutant gene was distal to DXS255 but proximal to the Duchenne muscular dystrophy locus on Xp. Thus, the gene that causes X-linked recessive nephrolithiasis maps to the pericentromeric region of the short arm of the X chromosome (Xpll.22), and further characterization of this gene will help to elucidate the factors controlling renal tubular function and mineral homeostasis. (J. Clin. Invest. 1993Invest. . 91:2351Invest. -2357 
Introduction
Hereditary nephrolithiasis with renal failure has recently been reported to occur as an X-linked recessive disorder in one large kindred from northern New York (1) . The disease occurred in males only, who suffered from nephrolithiasis, proteinuria, and renal tubular dysfunction in childhood, and from nephrocalcinosis and renal failure in early adulthood. The renal tubular dysfunction had similarities to the Fanconi syndrome (2) and was characterized by kaliuresis, phosphaturia, hypercalciuria, uricosuria, glycosuria, aminoaciduria, and an impaired ability to concentrate urine. However, a comparison of the clinical features of X-linked recessive nephrolithiasis (XRN) I to those of other X-linked renal disorders revealed important differences ( 1 ). For example, patients with XRN did not suffer from the ocular and cerebral manifestations associated with the Lowe syndrome (3), which is the only other reported X-linked Fanconi syndrome (4, 5) . In addition, patients with XRN did not suffer from deafness and the glomerular basement membrane splitting characteristic of Alport's syndrome (6) , which is also an X-linked disorder (7) associated with renal failure. The primary pathogenic abnormality causing the renal tubular dysfunction ofXRN is unknown. As a step towards elucidating the molecular pathology of this disorder we have performed linkage studies in this family from northern New York, and have localized the mutant gene causing XRN to the pericentromeric region of the short arm of the X chromosome (Xpl 1.22).
Methods
Patients. 102 living members from five generations of the previously described family (1) with XRN were investigated. The phenotype of XRN in these family members was established by the finding of nephrolithiasis or hematuria, together with proteinuria and either renal insufficiency or renal tubular dysfunction, e.g., glycosuria, a concentrating defect or increased excretion ofpotassium, phosphate, calcium, urate, or amino acids. These criteria established the presence of the disorder only in males. Following the previous report (1) , an additional four males, who are individuals 111. 15, V. 1, V.6, and VI. 1 in Fig.  1 , were found to have XRN. Individual 111.15, who is 70 y old, has nephrolithiasis, proteinuria, and renal tubular dysfunction; individuals V. 1, V.6, and VI. 1, who are, respectively, 18 yr, 32 mo, and 6 yr old, have not been documented to have nephrolithiasis but have the urinary abnormalities associated with XRN. Thus, it was possible to diagnose XRN in males during early childhood (1), which allowed the allocation of affected or unaffected phenotypes. No female met the criteria for XRN and all females therefore were assigned an unaffected phenotype. However, a female was classified as a carrier of XRN if males in subsequent generations manifested the disease or if she was the daughter of an affected male. Thus, the 102 family members included: 10 affected males; 47 unaffected males (including 7 spouses of female carriers); 15 female carriers; and 30 unaffected females.
Genetic markers. Two types of genetic markers were used to maximise the yield of information obtained from the study of polymorphisms in this single family. Thus, RFLPs were detected by the use of cloned human X-chromosome fragments (5), and polymorphisms due to length variations in microsatellite tandem repetitive sequences (8, 9) for example ofthe dinucleotide cytosine-adenine, were .6 -4 6 -6 6--1 6 --6 6 --6 -6 .6 1- DNA was prepared by standard methods (10) and utilized to detect these two types of genetic polymorphisms.
DNA hybridization analysisfor RFLPs. 5 jg DNA was digested to completion with a fourfold excess ofan appropriate restriction enzyme, electrophoresed, and transferred to a nylon membrane (Hybond-N; Amersham Corp., Arlington Heights, IL) by Southern blotting (11) as previously described (12) . DNA probes were labeled with the use of a-32P dCTP by oligonucleotide-primed synthesis (13) . A total of 10 cloned DNA probes from the X-chromosome were used in the linkage studies (Fig. 2) . The Southern blot was hybridized as previously described (12) and autoradiography with dual intensifying screens and preflashed Fuji medical x-ray film was performed at -70°C for 1-5 d to reveal the restriction fragment length polymorphisms.
Microsatellite polymorphisms. A total of seven loci-revealing microsatellite polymorphisms from the X chromosome were used in linkage studies (Fig. 2) . Three of these loci (KAL [14] , DMD [15] , and DXS453 [16] ) were from the short arm and four others (DXS3 [17] , DXS456 [18] , DXS424 [19] , and HPRT [20] ) were from the long arm. Oligonucleotide primers, L and R (Table I) (Table I) of PCR amplification were performed. Each cycle consisted of: 30 s at 94°C to denature double-stranded DNA; 60 s at 55°C to 62°C (Table I) for primers L and R to anneal to their respective complementary sequences; and 45 s at 72°C for the extension of the DNA strands. These conditions were further modified for the use of the DMD primers as previously described (15). At the end of the 21-25 cycles, a period of 10 min at 72°C was allowed for extension of the DNA strands. 4 j1i of the PCR product was electrophoresed on 6% denaturing polyacrylamide gels at 20 mA for 5 h. The microsatellite polymorphisms were detected by autoradiography with dual intensifying screens and Fuji medical x-ray films at -70°C.
Somatic cell hybrids. Rodent-human hybrid cells, which contained a fragment of the human X chromosome as the only human X chromosome component, were used for further regional localization of the 2352 Scheinman, Pook, Wooding, Pang, Frymoyer, and Thakker The polymorphic DNA loci are shown juxtaposed to their region of origin on the short (p) and long (q) arms of the X chromosome. The DXS453 locus was localized to Xcen by using specific primers (Table  I) (26) and multipoint location scores were computed using the LINKMAP program (27) as described previously (28) . The fixed framework of markers required for multilocus linkage analysis was deduced from previously published genetic maps (29-32). A LOD score of +3 was taken to establish linkage between two loci. The frequency of XRN was taken as l0-4. Varying the frequency of the disease had no effect on the results of the linkage analysis. The estimates used for the restriction fragment length polymorphism and microsatellite polymorphism allele frequencies have been previously reported (33) . The penetrance of the mutant XRN gene has not been established. However, in keeping with Xlinked recessive disorders (3, 4, 5, 7, 28 ) the disease phenotype could be established in early childhood in males but not females, who undergo X-chromosome inactivation (4, 5, 28) . Thus, males could be allocated affected and unaffected phenotypes but females were all allocated an unaffected phenotype. To assess the effects ofan incorrect allocation of the unaffected phenotype we performed separate linkage analyses in which unaffected individuals were reclassified as unknown phenotypes. This excluded these individuals from analysis at the disease locus but enabled use to be made ofthe X-linked genetic marker data for the purposes ofdeducing haplotypes. Linkage analysis was thus performed in three separate ways: (a) with males classified either as affected or unaffected and all females classified as unaffected; (b) with the males classified as either affected or unaffected and the females classified as unknown phenotype; and (c) with the unaffected males and females classified as unknown phenotype.
Results
The inheritance of XRN in the 102 members ofthe family was consistent with that ofan X-linked recessive disorder, as previously described (1). The family proved informative for 10 Xlinked genetic markers, four from the short arm and six from the long arm, and the results of two-point linkage analysis, in which males were allocated an affected or unaffected phenotype and all females were allocated an unaffected phenotype, are shown in Table II . Linkage between XRN and the DXS255 locus was established with a peak LOD score of5.91, a recombination fraction (0) of 0.036, and a 95% confidence interval of 0.001 to 0.180, thereby localizing XRN to the pericentromeric region of the short arm of the X chromosome (Xpl 1.22). All the other X-linked RFLP loci gave negative or low LOD scores.
To assess the effects of an incorrect allocation ofthe unaffected phenotype, the peak LOD scores were also calculated using unknown phenotype allocations for these individuals. Varying the phenotype of the females from an unaffected to an unknown phenotype had no effect on the values of the LOD scores in Table II (Fig. 2) . In addition, PCR-amplified products were oballeles (1,6, 1, 3) defined, respectively, by the polymorphic loci tained from the cell lines lWlLA4.9, CF37, and SIN176, KAL, DMD, DXS255, and DXS453. Her affected son, VI. 1, which contained, respectively, the human X chromosome fragreveals segregation of XRN with the proximal loci DXS255 ments Xcen-Xpter, Xp21-Xqter, and an X chromosome and DXS453, but demonstrates recombination between XRN which was deleted for Xp22. 11-pl 1.23. No PCR product was and the distal locus DMD. This observation locates XRN proxobtained from the hybrid cell line containing Xp. These obserimal to the DMD locus. Analysis of the other branches of the vations localized DXS453 to the centromeric region (Xcen), family reveals further recombination between XRN and the and this provided a useful highly polymorphic genetic marker short arm loci. For example, the affected male IV.9 is recombifor this region.
nant for XRN and the proximal locus DXS453, and the afAn analysis of recombination events involving the short fected male V.7 is recombinant for XRN and the distal loci arm of the X chromosome helped further to localize the XRN KAL and DMD. The combined observations of multipoint locus. The pedigree in Fig. 1 shows 58 members (45 surviving crossovers from these affected males and additional unaffected Table III ).
males locate XRN distal to DXS453 and proximal to DMD, i.e., in the vicinity of DXS255. Recombinants between XRN and DXS255 were not observed in any affected males or carrier females. Examination of individual V.4, who is 28 y old and who has none of the abnormalities of XRN, revealed the presence ofthe affected haplotype (1, 6, 1, 3 The likelihood of each of the possible locations of XRN within the fixed order Xpter-KAL-DMD-DXS255-DXS453-Xcen was quantitatively assessed using the LINKMAP program. Analysis using the LINKMAP program yielded the location score curve shown in Fig. 3 . There is a high peak distal to the DXS255 locus and proximal to the DMD locus, maximum location score = 33.78, 0.031 Morgans distal to the DXS255 locus. There are four subsidiary peaks between Xcen and DXS453, between DXS453 and DXS255, between DMD and KAL, and between KAL and Xpter. The location score for each peak is 12.41 at 0.150 Morgans proximal to DXS453, 21.37 at 0.010 Morgans proximal to DXS255, 15.14 at 0.143 Morgans distal to DMD, and 2.17 at 0.350 Morgans distal to KAL. The odds ratio for a location of XRN in each one of these segments is shown in Table III . This reveals that the odds ratio favoring the order Xpter-KAL-DMD-XRN-DXS255-DXS453-Xcen versus a location of XRN unlinked to this cluster of four loci is > 21.6 million: 1. In addition, the odds ratio favoring two other locations of XRN within the framework of the four loci are also significant. The odds ratio for a location of XRN distal to DMD and proximal to KAL is 1,900:1 and the odds ratio for a location of XRN proximal to DXS255 and distal to DXS453 is 43,700: 1. Thus, a proximal as opposed to distal location of XRN to DMD is 11,000 times (i.e., 21.6 million . 1,900) more likely, and a distal as opposed to proximal location of XRN to DXS255 is 495 times (i.e., 21.6 million + 43,700) more likely. These results indicate that XRN maps between DMD and DXS255. All the other odds ratios for possible locations of XRN within this framework of loci are < 1,000: 1. These results of multipoint linkage analysis demonstrate that the most likely order of genetic loci is Xpter-KAL-DMD-XRN-DXS255-DXS453-Xcen.
Discussion
Our linkage study of XRN using 17 polymorphic markers to explore X chromosome recombination has established linkage between XRN and the DXS255 locus defined by the polymor- (30, 32, 34) . Thus, the results of our study demonstrating linkage between the disease gene and this genetic marker maps XRN to the pericentromeric region ofthe short arm of the X chromosome. Analysis of the multipoint crosses observed on the short arm of the X chromosome in the family with XRN suggests that XRN maps between the DXS255 and DMD loci. The LINKMAP program is able to use information from a number of multipoint crosses to calculate the most likely location of one unmapped gene in a framework of well mapped markers (27) . Within the order Xpter-KAL-DMD-DXS255-DXS453-Xcen, a location of XRN between DXS255 and DMD was favored above all other locations (Table III) . The odds favoring the location of XRN distal to DXS255 are 495:1 and those favoring a location proximal to DMD are 11,000: 1. The genetic distance between DMD and DXS255 has been estimated to be 20 centiMorgans (30, 32) and an examination of the known cloned and mapped genes (33) to this region of Xp has not revealed a potential candidate gene for XRN. The additional polymorphic markers DXS84 and OTC (Fig. 2) were therefore utilized to define a more precise genetic map around XRN. The family proved uninformative for these two loci and the map location of XRN could not be defined further. However, our mapping of XRN to this chromosomal segment has identified the region which needs to be investigated further by the use of other polymorphic genetic markers.
The mapping of XRN to Xp 11.22 demonstrates that a mutation at a locus distant from the Lowe's oculocerebrorenal (OCRL) syndrome and the Alport's syndrome gene is involved in altering renal tubular function and in renal failure. The OCRL gene, which is associated with renal tubular dysfunction and the Fanconi syndrome, has been mapped to Xq25-q26 (4), and the gene for Alport's syndrome, which is associated with nephritis and renal failure, has been mapped to Xq22 (7). In addition, cloning and characterization of the OCRL gene has revealed that the gene encodes a protein with homology to human inositol polyphosphate-5-phosphatase and that the disorder may be due to an inborn error of inositol phosphate metabolism (35) . Investigations of patients with the X-linked form of Alport's syndrome have revealed mutations in the collagen type IV alpha 5 (COL4A5) gene (36) . XRN, which maps to Xpl 1.22, is thus genetically and clinically a separate entity from the other two reported X-linked renal disorders. XRN is associated with the Fanconi syndrome, and a possible role for an inborn error in inositol phosphate metabolism similar to that for OCRL needs to be elucidated. The precise mapping of the XRN gene to Xpl 1.22 by our linkage study represents an important step towards understanding the role of this gene in regulating renal tubular function and in identifying the metabolic defect. Our localization ofthis mutant gene identifies the chromosomal segment in which a concentrated search for deletions and closer genetic markers is required to further elucidate the factors controlling renal tubular transport and the precipitation of renal calculi.
